Nanocarrier Based Vaccine Market Overview
The Nanocarrier Based Vaccine Market is transforming global immunization strategies through advanced nanotechnology delivery systems. Valued at USD 2,500 million in 2024, this market is projected to reach USD 8.0 billion by 2035, growing at a robust CAGR of 11.0%. Nanocarriers enhance vaccine stability, improve antigen delivery, and enable targeted immune responses that traditional formulations...
0 Comments 0 Shares 5 Views 0 Reviews